These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 20585090)

  • 1. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
    Hershman DL; Kushi LH; Shao T; Buono D; Kershenbaum A; Tsai WY; Fehrenbacher L; Gomez SL; Miles S; Neugut AI
    J Clin Oncol; 2010 Sep; 28(27):4120-8. PubMed ID: 20585090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
    Hershman DL; Shao T; Kushi LH; Buono D; Tsai WY; Fehrenbacher L; Kwan M; Gomez SL; Neugut AI
    Breast Cancer Res Treat; 2011 Apr; 126(2):529-37. PubMed ID: 20803066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer.
    He W; Fang F; Varnum C; Eriksson M; Hall P; Czene K
    J Clin Oncol; 2015 Jul; 33(20):2262-9. PubMed ID: 26033800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer.
    Neugut AI; Zhong X; Wright JD; Accordino M; Yang J; Hershman DL
    JAMA Oncol; 2016 Oct; 2(10):1326-1332. PubMed ID: 27281650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients.
    He W; Smedby KE; Fang F; Olsson H; Margolin S; Hall P; Czene K
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28423398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.
    Neugut AI; Subar M; Wilde ET; Stratton S; Brouse CH; Hillyer GC; Grann VR; Hershman DL
    J Clin Oncol; 2011 Jun; 29(18):2534-42. PubMed ID: 21606426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.
    Wigertz A; Ahlgren J; Holmqvist M; Fornander T; Adolfsson J; Lindman H; Bergkvist L; Lambe M
    Breast Cancer Res Treat; 2012 May; 133(1):367-73. PubMed ID: 22286315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients.
    Tervonen HE; Daniels B; Tang M; Preen DB; Pearson SA
    Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):812-820. PubMed ID: 30861596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer.
    Nekhlyudov L; Li L; Ross-Degnan D; Wagner AK
    Breast Cancer Res Treat; 2011 Nov; 130(2):681-9. PubMed ID: 21842245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer.
    Hershman DL; Tsui J; Meyer J; Glied S; Hillyer GC; Wright JD; Neugut AI
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25349080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution.
    Hwang GS; Paranjpe R; Opsomer C; Lu K; Abajue U; Abughosh S; Zaghloul H; Trivedi MV
    Clin Breast Cancer; 2020 Dec; 20(6):520-526. PubMed ID: 32669209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related differences in persistence in women with breast cancer treated with tamoxifen or aromatase inhibitors in Germany.
    Jacob L; Hadji P; Kostev K
    J Geriatr Oncol; 2016 May; 7(3):169-75. PubMed ID: 27091510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival: a population-based study in Catalonia, Spain.
    Font R; Espinas JA; Barnadas A; Izquierdo A; Galceran J; Saladie F; Marcos-Gragera R; Torrent A; Manchon-Walsh P; Borras JM
    Breast Cancer Res Treat; 2019 Jun; 175(3):733-740. PubMed ID: 30887164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk.
    Pistilli B; Paci A; Ferreira AR; Di Meglio A; Poinsignon V; Bardet A; Menvielle G; Dumas A; Pinto S; Dauchy S; Fasse L; Cottu PH; Lerebours F; Coutant C; Lesur A; Tredan O; Soulie P; Vanlemmens L; Jouannaud C; Levy C; Everhard S; Arveux P; Martin AL; Dima A; Lin NU; Partridge AH; Delaloge S; Michiels S; André F; Vaz-Luis I
    J Clin Oncol; 2020 Aug; 38(24):2762-2772. PubMed ID: 32568632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
    Kuba S; Maeda S; Matsumoto M; Yamanouchi K; Yano H; Morita M; Sakimura C; Hatachi T; Tokai Y; Takatsuki M; Fujioka H; Hayashida N; Nagayasu T; Eguchi S
    Clin Breast Cancer; 2018 Apr; 18(2):150-156. PubMed ID: 29290564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer.
    Reeder-Hayes KE; Mayer SE; Lund JL
    Cancer; 2021 Apr; 127(8):1220-1227. PubMed ID: 33508140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer.
    Abdel-Qadir H; Amir E; Fischer HD; Fu L; Austin PC; Harvey PJ; Rochon PA; Lee DS; Anderson GM
    Eur J Cancer; 2016 Nov; 68():11-21. PubMed ID: 27693889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to adjuvant hormonal therapy in localised breast cancer.
    Davies S; Voutsadakis IA
    Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13729. PubMed ID: 36207823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.
    Blanchette PS; Lam M; Richard L; Allen B; Shariff SZ; Vandenberg T; Pritchard KI; Chan KKW; Louie AV; Desautels D; Raphael J; Earle CC
    Breast Cancer Res Treat; 2020 Jan; 179(1):217-227. PubMed ID: 31571072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.
    Simon R; Latreille J; Matte C; Desjardins P; Bergeron E
    Can J Surg; 2014 Feb; 57(1):26-32. PubMed ID: 24461223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.